#celltherapy — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #celltherapy, aggregated by home.social.
-
DATE: May 24, 2026 at 07:51AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists “recharge” damaged nerves to ease chronic pain
URL: https://www.sciencedaily.com/releases/2026/05/260523103950.htm
For millions battling chronic nerve pain, even the softest touch can feel agonizing — but scientists may have uncovered a radically new way to stop it at the source. Researchers at Duke University found that damaged nerves can be revived by supplying them with healthy mitochondria, the tiny energy producers inside cells.
URL: https://www.sciencedaily.com/releases/2026/05/260523103950.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #ChronicPain #NervePain #MitochondriaHealing #Neuroscience #DukeUniversity #NeurologyResearch #PainRelief #MedicalBreakthrough #CellTherapy #NerveRegeneration
-
https://www.europesays.com/ch/65806/ Stroke Awareness Month: What You Should Know About Your Stroke Risk #AtrialFibrillation #CardiovascularDisease #CellTherapy #DiseaseAwareness #GeneTherapy #GeneticDisease #GlobalHealthcareCompanies #HeartDisease #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals #stroke #StrokeAwarenessMonth #StrokeRisk
-
https://www.europesays.com/ch/65358/ How This Former Army Officer Helps Deliver Cancer Treatments to Patients, Through Hurricanes and Beyond #Careers #CellTherapy #EmergingTechnology #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #Oncology #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals #TargetedTherapy #WorkingAtNovartis
-
https://www.europesays.com/dk/80028/ Novo Nordisk Refocuses On GLP‑1 As AI Partner Advances Parkinson’s Bet #CellTherapy #Intelligence #NovoNordisk #Parkinson'sDisease #RegenerativeMedicine
-
https://www.europesays.com/dk/79980/ Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior #ArtificialIntelligence #Biotechnology #CellTherapy #CellularIntelligence #ClinicalTrials #DopaminergicNeurons #DrugDevelopment #MichaBreakstone #neurology #NovoNordisk #Parkinson'sDisease #SomiteAI #StemCellResearch #STEMPD #VentureCapital
-
https://www.europesays.com/dk/79740/ Cellular Intelligence and Novo Nordisk to advance Parkinson’s cell therapy #AI #biology #CellTherapy #Deals #FDAFoodAndDrugAdministration #NovoNordisk #Parkinson #ResearchAndDevelopment
-
Viral-Vector Transfection Reagents Market in Poland | Report – IndexBox https://www.byteseu.com/1997349/ #BiopharmaMarketReport #CART)LentiviralVectorProduction #CellTherapy(eG #forecast #GeneTherapyViralVectorProduction #HighThroughputScreeningForOptimization #LipidNanoparticleFormulation #MarketAnalysis #Poland #PolymerChemistry #ResearchScaleVectorProductionForPreclinicalStudies #ScaleDownModelsForProcessDevelopment #VaccineVectorProduction #ViralVectorTransfectionReagents
-
UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?
https://biotech.industryexaminer.com/ucb-neurona-epilepsy-cell-therapy-bet/
#Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews -
UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?
https://biotech.industryexaminer.com/ucb-neurona-epilepsy-cell-therapy-bet/
#Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews -
UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?
https://biotech.industryexaminer.com/ucb-neurona-epilepsy-cell-therapy-bet/
#Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews -
UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?
https://biotech.industryexaminer.com/ucb-neurona-epilepsy-cell-therapy-bet/
#Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews -
UCB’s $1.15B Neurona Therapeutics acquisition is a high-stakes bet on cell therapy in epilepsy. The bigger question: can biotech move from suppressing seizures to repairing brain circuits?
https://biotech.industryexaminer.com/ucb-neurona-epilepsy-cell-therapy-bet/
#Biotech #UCB #NeuronaTherapeutics #Epilepsy #CellTherapy #TechNews -
https://www.europesays.com/ch/49826/ Supercharged Ireland | Business Powered By AI #CellTherapy #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals
-
https://www.europesays.com/ch/48248/ New long term social impact and sustainability targets #CellTherapy #GeneTherapy #GlobalHealthcareCompanies #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #sandoz #SandozPharmaceuticals
-
https://www.europesays.com/ch/41164/ Changing Lives: Inside the Novartis Corporate Teen Mentoring Program #Careers #CellTherapy #digital #GeneTherapy #GlobalHealthcareCompanies #Innovation #InnovativeHealthcare #InnovativeMedicines #Novartis #NovartisOncologyPipeline #NovartisPharmaceuticals #OncologyDrugDevelopment #RareDiseasePatients #RareDiseaseTreatment #ReimagineMedicine #sandoz #SandozPharmaceuticals #WorkingAtNovartis
-
Could autologous cell therapy be a next option in treatment of diabetic kidney disease?
Read the excellent blog post at NephJC
-
Could autologous cell therapy be a next option in treatment of diabetic kidney disease?
Read the excellent blog post at NephJC
-
Could autologous cell therapy be a next option in treatment of diabetic kidney disease?
Read the excellent blog post at NephJC
-
Could autologous cell therapy be a next option in treatment of diabetic kidney disease?
Read the excellent blog post at NephJC
-
Could autologous cell therapy be a next option in treatment of diabetic kidney disease?
Read the excellent blog post at NephJC
-
Quick Stem Cells Lab Guide from BioResire!
Master self-renewal, types like iPSCs, and regenerative applications.
Contact for internships: [email protected] #StemCells #StemCellTherapy #RegenerativeMedicine #iPSCs #StemCellResearch #Biotechnology #BioResire #LifeSciences #PluripotentStemCells #AdultStemCells #TissueEngineering #DrugTesting #Biotech #MolecularBiology #CellTherapy #StemCellTreatment #RegenerativeTherapy #BiotechInternship #Science #Biology -
Quick Stem Cells Lab Guide from BioResire!
Master self-renewal, types like iPSCs, and regenerative applications.
Contact for internships: [email protected] #StemCells #StemCellTherapy #RegenerativeMedicine #iPSCs #StemCellResearch #Biotechnology #BioResire #LifeSciences #PluripotentStemCells #AdultStemCells #TissueEngineering #DrugTesting #Biotech #MolecularBiology #CellTherapy #StemCellTreatment #RegenerativeTherapy #BiotechInternship #Science #Biology -
Gilead’s $7.8B Arcellx buy isn’t just M&A. It’s an “option exercise” on CAR-T: pay up to own the flywheel—manufacturing, label expansion, and the economics of scale.
https://biotech.industryexaminer.com/gilead-arcellx-78b-car-t-option-exercise-anito-cel/
#Biotech #CellTherapy #CART #Oncology #MergersAndAcquisitions #MultipleMyeloma
-
Gilead’s $7.8B Arcellx buy isn’t just M&A. It’s an “option exercise” on CAR-T: pay up to own the flywheel—manufacturing, label expansion, and the economics of scale.
https://biotech.industryexaminer.com/gilead-arcellx-78b-car-t-option-exercise-anito-cel/
#Biotech #CellTherapy #CART #Oncology #MergersAndAcquisitions #MultipleMyeloma
-
Gilead’s $7.8B Arcellx buy isn’t just M&A. It’s an “option exercise” on CAR-T: pay up to own the flywheel—manufacturing, label expansion, and the economics of scale.
https://biotech.industryexaminer.com/gilead-arcellx-78b-car-t-option-exercise-anito-cel/
#Biotech #CellTherapy #CART #Oncology #MergersAndAcquisitions #MultipleMyeloma
-
Gilead’s $7.8B Arcellx buy isn’t just M&A. It’s an “option exercise” on CAR-T: pay up to own the flywheel—manufacturing, label expansion, and the economics of scale.
https://biotech.industryexaminer.com/gilead-arcellx-78b-car-t-option-exercise-anito-cel/
#Biotech #CellTherapy #CART #Oncology #MergersAndAcquisitions #MultipleMyeloma
-
Gilead’s $7.8B Arcellx buy isn’t just M&A. It’s an “option exercise” on CAR-T: pay up to own the flywheel—manufacturing, label expansion, and the economics of scale.
https://biotech.industryexaminer.com/gilead-arcellx-78b-car-t-option-exercise-anito-cel/
#Biotech #CellTherapy #CART #Oncology #MergersAndAcquisitions #MultipleMyeloma
-
Johnson & Johnson will invest over $1 billion to build a cutting-edge cell therapy plant in Pennsylvania, creating thousands of jobs as part of a $55 billion US investment plan through 2029.
#YonhapInfomax #JohnsonAndJohnson #CellTherapy #Investment #Pennsylvania #BiomanufacturingJobs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=105985 -
Johnson & Johnson will invest over $1 billion to build a cutting-edge cell therapy plant in Pennsylvania, creating thousands of jobs as part of a $55 billion US investment plan through 2029.
#YonhapInfomax #JohnsonAndJohnson #CellTherapy #Investment #Pennsylvania #BiomanufacturingJobs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=105985 -
Johnson & Johnson will invest over $1 billion to build a cutting-edge cell therapy plant in Pennsylvania, creating thousands of jobs as part of a $55 billion US investment plan through 2029.
#YonhapInfomax #JohnsonAndJohnson #CellTherapy #Investment #Pennsylvania #BiomanufacturingJobs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=105985 -
Johnson & Johnson will invest over $1 billion to build a cutting-edge cell therapy plant in Pennsylvania, creating thousands of jobs as part of a $55 billion US investment plan through 2029.
#YonhapInfomax #JohnsonAndJohnson #CellTherapy #Investment #Pennsylvania #BiomanufacturingJobs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=105985 -
I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.
Here's an excellent update on research from my friend Paul Heltzel:
https://diatribe.org/diabetes-research/state-cure-cell-therapy-breakthroughs
-
I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.
Here's an excellent update on research from my friend Paul Heltzel:
https://diatribe.org/diabetes-research/state-cure-cell-therapy-breakthroughs
-
I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.
Here's an excellent update on research from my friend Paul Heltzel:
https://diatribe.org/diabetes-research/state-cure-cell-therapy-breakthroughs
-
I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.
Here's an excellent update on research from my friend Paul Heltzel:
https://diatribe.org/diabetes-research/state-cure-cell-therapy-breakthroughs
-
I've been closely following the quest for cell therapy "cures" for type 1 diabetes ever since my son was diagnosed with the disease 25 years ago.
Here's an excellent update on research from my friend Paul Heltzel:
https://diatribe.org/diabetes-research/state-cure-cell-therapy-breakthroughs
-
🧫 Stem Cells — Jan 2026
• Developmental origin shapes fibroblast function and scarring
• Stem and stromal plasticity influence tumor immunity
• Metabolic stress impairs intestinal stem cell repair
• Organoids and engineered niches enhance lineage modeling and engraftment -
🧫 Stem Cells — Jan 2026
• Developmental origin shapes fibroblast function and scarring
• Stem and stromal plasticity influence tumor immunity
• Metabolic stress impairs intestinal stem cell repair
• Organoids and engineered niches enhance lineage modeling and engraftment -
🧫 Stem Cells — Jan 2026
• Developmental origin shapes fibroblast function and scarring
• Stem and stromal plasticity influence tumor immunity
• Metabolic stress impairs intestinal stem cell repair
• Organoids and engineered niches enhance lineage modeling and engraftment -
🧫 Stem Cells — Jan 2026
• Developmental origin shapes fibroblast function and scarring
• Stem and stromal plasticity influence tumor immunity
• Metabolic stress impairs intestinal stem cell repair
• Organoids and engineered niches enhance lineage modeling and engraftment -
🧫 Stem Cells — Jan 2026
• Developmental origin shapes fibroblast function and scarring
• Stem and stromal plasticity influence tumor immunity
• Metabolic stress impairs intestinal stem cell repair
• Organoids and engineered niches enhance lineage modeling and engraftment -
🧬 Gene Editing — Jan 2026
• CRISPR-Cas3 enables high-efficiency hepatic editing in vivo
• Advanced base editors expand precision mutagenesis capacity
• CAR-T approaches extend into autoimmune disease
• Editing and RNA regulation uncover new fibrosis and immune targets -
Meet the #HEAL team! Led by Dr. Robert Zweigerdt & Prof. Dr. Ulrich Martin (MHH, Germany), the project brings together 10 partners from Europe & Israel
#HEALproject #celltherapy -
Exciting news from the #HEAL project! The EU is funding a groundbreaking research project to develop a new cell therapy for regenerating damaged hearts. Led by Medical School Hannover, the project aims to overcome scientific, regulatory & safety hurdles for a first-in-man clinical trial. #celltherapy #heartdisease #regenerativemedicine #HEALproject
-
Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional News
NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #accesstomedicines #celltherapy #drugproductmanufacturingfacility #Health #joaquinduato #Johnson&Johnson #medicationcosts #MERCK&CO #Pennsylvania #Sanofi #TrumpAdministration #TrumpRx #trumprx.com
https://www.newsbeep.com/us/398424/ -
Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional News
NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #accesstomedicines #celltherapy #drugproductmanufacturingfacility #Health #joaquinduato #Johnson&Johnson #medicationcosts #MERCK&CO #Pennsylvania #Sanofi #TrumpAdministration #TrumpRx #trumprx.com
https://www.newsbeep.com/us/398424/ -
AcouSort and MFX Collaborate on Cell Therapy
AcouSort and MFX are collaborating to evaluate integrating AcouSort's technology with MFX's bioreactor systems. The partnership intends to improve cell therapy manufacturing efficiency, focusing on sample processing times and transfer to cell expansion. MFX is part of the EcoCAR Consortium, working with UK partners on sustainable CAR-T cell production.
-
AcouSort and MFX Collaborate on Cell Therapy
AcouSort and MFX are collaborating to evaluate integrating AcouSort's technology with MFX's bioreactor systems. The partnership intends to improve cell therapy manufacturing efficiency, focusing on sample processing times and transfer to cell expansion. MFX is part of the EcoCAR Consortium, working with UK partners on sustainable CAR-T cell production.
-
AcouSort and MFX Collaborate on Cell Therapy
AcouSort and MFX are collaborating to evaluate integrating AcouSort's technology with MFX's bioreactor systems. The partnership intends to improve cell therapy manufacturing efficiency, focusing on sample processing times and transfer to cell expansion. MFX is part of the EcoCAR Consortium, working with UK partners on sustainable CAR-T cell production.
-
AcouSort and MFX Collaborate on Cell Therapy
AcouSort and MFX are collaborating to evaluate integrating AcouSort's technology with MFX's bioreactor systems. The partnership intends to improve cell therapy manufacturing efficiency, focusing on sample processing times and transfer to cell expansion. MFX is part of the EcoCAR Consortium, working with UK partners on sustainable CAR-T cell production.